Platelet aggregation and intracellular calcium mobilisation responses are enhanced by cyclosporin A but not by pimecrolimus (SDZ ASM 981)

Platelets

Volumn 13, Issue 4, 2002, Pages 213-218

  Fox, Sue C ^a   Judge, H M ^a   Allen, B R ^a   Heptinstall, S ^a  

^a QUEEN S MEDICAL CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; CYCLOSPORIN A; CYTOKINE; DESULFATOHIRUDIN; PIMECROLIMUS; RECOMBINANT HIRUDIN; CYCLOSPORIN; DRUG DERIVATIVE; IMMUNOSUPPRESSIVE AGENT; TACROLIMUS;

ANTICOAGULATION; ARTICLE; BLOOD SAMPLING; BODY SURFACE; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; DRUG EFFECT; EXTRACELLULAR CALCIUM; FLOW CYTOMETRY; HUMAN; HUMAN CELL; KIDNEY TRANSPLANTATION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; CALCIUM SIGNALING; DRUG POTENTIATION; INSTRUMENTATION; KINETICS; PHOTOMETRY;

ADENOSINE DIPHOSPHATE; CALCIUM SIGNALING; CYCLOSPORINE; DRUG SYNERGISM; FLOW CYTOMETRY; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KINETICS; NEPHELOMETRY AND TURBIDIMETRY; PLATELET AGGREGATION; PLATELET COUNT; TACROLIMUS;

EID: 0036077348     PISSN: 09537104     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Thromboembolic complications and haemostatic changes in cyclosporin-treated cadaveric kidney allograft recipients
2. Cyclosporin enhances platelet aggregation
3. Evidence for chronic platelet hyperaggregability and in vivo activation in cyclosporin-treated renal allograft recipients
4. Increased platelet activation in renal transplant patients
5. Cyclosporine A and FK 506 affect platelet functions in vitro
6. Cyclosporin A augments human platelet sensitivity to aggregating agents by increasing fibrinogen receptor availability
7. Potential mechanism of cyclosporin A-induced vascular smooth muscle contraction
8. Cyclosporine A augments angiotensin II-stimulated rise in intracellular free calcium in vascular smooth muscle cells
9. 2+ fluxes in isolated hepatocytes
10. 2+ mobilization and contraction in mesangial cells
11. The effect of cyclosporine on calcium, protein kinase C and sodium-proton exchange in platelets
12. Platelet activation is increased in Cyclosporin A-induced hypertensive rats
13. Adenosine diphosphate-induced platelet aggregation and release reaction in heparinized platelet rich plasma and the influence of added citrate
14. The effects of citrate and extracellular calcium ions on the platelet release reaction induced by adenosine diphosphate and collagen
15. Dependence of human-platelet functional-responses on divalent-cations - Aggregation and secretion in heparin-anticoagulated and hirudin-anticoagulated platelet-rich plasma and the effects of chelating-agents
16. Influence of different anticoagulants on platelet aggregation in whole blood; a comparison between citrate, low molecular mass heparin and hirudin
17. Investigations on spontaneous aggregation and platelet responses to streptokinase and to adrenaline during pregnancy
18. Platelet functions in recombinant hirudin-anticoagulated blood
19. The effects of recombinant hirudin on various platelet functions
20. Recombinant hirudin - A suitable anticoagulant in human platelet function assessment
21. Platelet aggregation in whole blood determined using the Ultra-Flo 100 Whole Blood Platelet Counter
22. Factors that contribute to spontaneous platelet aggregation and streptokinase-induced aggregation in whole blood
23. Differential effects of glycoprotein IIb/IIIa antagonists on platelet microaggregate and macroaggregate formation and effect of anticoagulant on antagonist efficacy: Implications for assay methodology and comparison of different antagonists
24. Platelet aggregation: The use of optical density fluctuations to study microaggregate formation in platelet suspension
25. Ascomycins: Promising agents for the treatment of inflammatory skin diseases
26. First experience of topical SDZ ASM 981 in children with atopic dermatitis
27. SDZ ASM 981: An emerging safe and effective treatment for atopic dermatitis
28. 2+ in platelet and neutrophils
29. Cyclosporine A enhances agonist-induced aggregation of human platelets by stimulating protein phosphorylation
30. Expression and function of calcineurin in the mammalial nephron: Physiological roles, receptor signalling and ion transport
31. Cyclosporin A enhances total cell calcium independant of Na-K-ATPase in vascular smooth muscle cells
32. Enhancement of human platelet aggregation and secretion induced by rapamycin
33. Rapamycin potentiates agonist-induced human platelet activation: Synergistic effects of rapamycin and cyclosporin